DocuTwin · executable-demo
DocuTwin Documentation Review Demo
Demonstrate draft-only documentation support that preserves authorship, source trace, missing context, and review control.
Synthetic scenario
A synthetic documentation packet produces a reviewable draft state, source trace, missing-context prompts, and blocked final-signature action.
Run DocuTwin workflow demoInspectable proof
Workflow, result, governance, and quality evidence remain one click away.
Workflow result
Draft-only result fixture with source trace and review state.
Inspect Workflow resultDocuTwin module
Documentation workflow scope and clinician-control boundary.
Inspect DocuTwin moduleAgentOS evaluation
Interactive synthetic document evaluation with Trust Card output.
Inspect AgentOS evaluationCommercial path
Recommended next step: 60-Day Governed Automation Pilot
$125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.
Clinical documentation, ambulatory operations, quality, and CMIO teams.
- SCRIMED does not compete as a commodity monthly scribe seat.
- The value is governed draft review, source trace, missing context, and implementation readiness.
- Final note signature and EHR filing remain out of scope.
Draft note structure
Documentation review friction reduced
Source trace
Source trace completeness
Missing-context prompts
Missing context surfaced
Clinician review checklist
Clinician control retained
Governance boundary
Human-reviewed synthetic evaluation only.
- Licensed clinician review remains required.
- Synthetic encounter packet only.
- Draft output cannot become a final clinical record.
Share the buyer, proof path, outcomes, governance boundaries, and exclusions.
RunRun DocuTwin workflow demoInspect the current executable synthetic product surface.
PilotCompare pilot programsChoose a structured engagement with outcomes, inputs, gates, and exclusions.
AcceleratorMap price and pilot pathUse market-aligned packaging before custom buyer work expands.
RequestRequest this evaluationStart a governed buyer intake without submitting PHI.